Bastide Le Confort Médical SA (EPA:BLC)
France · Delayed Price · Currency is EUR 19.60
+0.44 (2.30%)
Oct 2, 2026, 5:35 PM CET
EPA:BLC Market Cap
EPA:BLC has a market cap or net worth of €145.28 million as of October 2, 2026. Its market cap has decreased by -21.17% in one year.
Market Cap
145.28M
Enterprise Value
443.63M
Revenue
510.46M
Ranking
n/a
PE Ratio
16.22
Stock Price
€19.60
ChartMarket Cap Chart
Since May 22, 1997, EPA:BLC's market cap has increased from 10.73M to 145.28M, an increase of 1,253.80%. That is a compound annual growth rate of 9.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 145.28M | -17.19% |
| Dec 31, 2025 | 175.44M | -0.18% |
| Dec 31, 2024 | 175.75M | -10.17% |
| Dec 29, 2023 | 195.66M | -27.00% |
| Dec 30, 2022 | 268.04M | -18.51% |
| Dec 31, 2021 | 328.91M | -11.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 87.58B |
| EssilorLuxottica Société anonyme | 66.46B |
| Sartorius Stedim Biotech | 20.70B |
| Eurofins Scientific SE | 12.94B |
| Transgene | 195.55M |
| Cegedim | 151.86M |
| Median Technologies | 143.12M |
| Innate Pharma | 131.37M |